Ledermann, J., Colombo, N., Oza, A., Fujiwara, K., Birrer, M., Randall, L., Poddubskaya, E., Scambia, G., Shparyk, Y., Lim, M., Lim, M., Sohn, J., Yonemori, K., Stewart, R., Zhang, X., Perkins Smith, J., Linn, C., & Monk, B. (n.d.). 1 Avelumab in combination with and/or following chemotherapy vs chemotherapy in treatment-naive patients with ovarian cancer: biomarker analyses from the phase 3 JAVELIN Ovarian 100 trial. International journal of gynecological cancer, 30, A1. http://access.bl.uk/ark:/81055/vdc_100144717024.0x000017